EU → North America Device Access

Leica Biosystems Newcastle Ltd

GB-MF-000020595 · United Kingdom · Newcastle Upon Tyne

Leica Biosystems Newcastle Ltd is registered in the European database on medical devices as a manufacturer, with 306 devices declared. It is also registered as a device establishment with the U.S. FDA.

What this manufacturer declares

Most frequent device types declared: KBI-XL006, KBI-XL015, NCL-L-E-Cad, NCL-L-END, NCL-L-LL002.

Authorised representative in the Union: AR Experts B.V..

Devices declared under this manufacturer

Showing 12 of 306 declared devices.

Catalogue references include KBI-XL006, KBI-XL015, NCL-L-E-Cad, NCL-L-END, NCL-L-LL002, NCL-L-MSH6.

European nomenclature codes declared: W01030709, W01060299, W0103010199, W01030799, W01030703, W01030711.

United States market access

FDA establishment registerRegistered with FDA
Matched entryLEICA BIOSYSTEMS NEWCASTLE LTD (GB) · FDA 3004859032
Devices in EUDAMED306
Country of registrationUnited Kingdom

Device-level evidence

Devices with a numeric GTIN306
Found in the U.S. device database264
Share86.3 %

Canadian market access

Health Canada licence listingLicensed in Canada
Matched entryLEICA BIOSYSTEMS NEWCASTLE LTD.

What it holds in Canada

Licences on record295
Currently active0
Class 2 devices294
Class 3 devices1
First licensed2005-03-30

Licence types: Single Device (167), Device Family (116), Test Kit (8), System (2).

Licensed under: NOVOCASTRA LIQUID MOUSE MONOCLONAL ANTIBODY CD, MOUSE MONOCLONAL CD10-270, MOUSE MONOCLONALS DYS1/2/3, MOUSE MONOCLONAL CD5-4C7, MOUSE MONOCLONAL KI67-MM1, NOVOCASTRA LIQUID MOUSE MONOCLONAL ANTIBODY EN.

North American profile: Both markets. Leica Biosystems Newcastle Ltd is registered in both the United States and Canada.

Notified body certificates

CertificateStatusExpiry
IVDR 739320reissued2031-06-07

Other manufacturers in United Kingdom

All United Kingdom manufacturers →